March 31, 2023 Chase C. Leavitt Oncternal Therapeutics, Inc. Dear Mr. Leavitt:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Oncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated April 12, 2021 (the “Employment Agreement”).
March 31, 2023 James Breitmeyer, M.D., Ph.D. Oncternal Therapeutics, Inc. Dear Dr. Breitmeyer:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Oncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated September 12, 2019 (the “Employment Agreement”).
March 31, 2023 Salim Yazji, M.D. Oncternal Therapeutics, Inc. Dear Dr. Yazji:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Oncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated May 17, 2021 (the “Employment Agreement”).
March 31, 2023 Richard Vincent Oncternal Therapeutics, Inc. Dear Mr. Vincent:Oncternal Therapeutics, Inc. • May 4th, 2023 • Pharmaceutical preparations
Oncternal Therapeutics, Inc. (the “Company”) is providing this letter agreement to set forth agreements between you and the Company related to your compensation. This letter agreement amends the Employment Agreement between you and the Company, dated September 12, 2019 (the “Employment Agreement”).
